On 21 April 2018
Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company on 21 April 2018, to issue equity shares on a preferential basis, in one or more tranches to group of Strategic investor, not forming part of promoter & promoter group, as per the applicable laws including SEBI regulations, subject to the approval of the Members of the Company.Powered by Capital Market - Live News